4
Changes in Ownership
CAPRICOR THERAPEUTICS, INC. Filed Acc 0001593087-26-000007
CHIEF FINANCIAL OFFICER sold 25,000 shares at $31.70 ($792,540)
- CHIEF FINANCIAL OFFICER acquired 25,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergmann Anthony CHIEF FINANCIAL OFFICER | 2026-05-01 | Option exercise 10b5-1 | +25,000 | $3.18 | $79,500 | 33,223 | D |
| Bergmann Anthony CHIEF FINANCIAL OFFICER | 2026-05-01 | Sale 10b5-1 | −25,000 | $31.70 | $792,540 | 8,223 | D |
| Derivatives | |||||||
| Bergmann Anthony CHIEF FINANCIAL OFFICER | 2026-05-01 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 116,980 | D | ||
| Open-market sales · 25,000 sh · avg $31.70 · $792,540 | |||||||
Loading xslF345X06/form4-05042026_040501.xml…